ArtVentive Medical Group, Inc.: 10-K filed 2016-04-14

Name: ArtVentive Medical Group, Inc.: 10-K filed 2016-04-14
Creator: ArtVentive Medical Group, Inc.
License: https://creativecommons.org/licenses/by/4.0/

What ArtVentive Medical Group, Inc. reported in its annual report filed 2016-04-14 (fiscal FY 2015): 24 published measures, 46 facts as tagged in accession 0001056520-16-000234.

This filing

Form: 10-K (annual report)
Filed: 2016-04-14
Fiscal period: fiscal FY 2015
Accession: 0001056520-16-000234 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ArtVentive Medical Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-12-31	453,416	USD
At 2014-12-31	188,971	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-12-31	-970,673	USD
At 2014-12-31	-1,575,726	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	-3,547,631	USD	365
2014-01-01 to 2014-12-31	-6,272,967	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	-8,917	USD	365
2014-01-01 to 2014-12-31	-1,573	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	230,154	USD	365
2014-01-01 to 2014-12-31	111,732	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	3,050,050	USD	365
2014-01-01 to 2014-12-31	4,700,000	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	-8,917	USD	365
2014-01-01 to 2014-12-31	-1,573	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-12-31	17,288	USD
At 2014-12-31	12,486	USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-12-31	354,598	USD
At 2014-12-31	151,478	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-12-31	924,089	USD
At 2014-12-31	1,264,697	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-12-31	924,089	USD
At 2014-12-31	221,397	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	3,547,636	USD	365
2014-01-01 to 2014-12-31	6,273,666	USD	365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	1,934,928	USD	365
2014-01-01 to 2014-12-31	3,142,652	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	1,608,593	USD	365
2014-01-01 to 2014-12-31	3,127,850	USD	365

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-12-31	17,028,580	USD
At 2014-12-31	12,879,982	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-12-31	-9,582	USD
At 2014-12-31	-5,467	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-12-31	1,043,300	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	-3,547,631	USD	365
2014-01-01 to 2014-12-31	-6,272,967	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	-3,547,631	USD	365
2014-01-01 to 2014-12-31	-6,272,967	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	4,115	USD	365
2014-01-01 to 2014-12-31	3,164	USD	365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	800	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	4,544	USD	365
2014-01-01 to 2014-12-31	-22,662	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	-279,306	USD	365
2014-01-01 to 2014-12-31	3,165	USD	365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-12-31	702,692	USD	365
2014-01-01 to 2014-12-31	-51,112	USD	365

Inspect the source

Entity: ArtVentive Medical Group, Inc. / CIK 0001405249
Captured: 2026-09-23 02:53 UTC
SEC response SHA-256: 01b8937f2876d513617b1d921d4a98ec6f536680d197470785bad286f4947f07

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001405249.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))